KEY POINTS:
Government drug-buying agency Pharmac has approved funding for a new drug for breast-cancer sufferers.
Pharmac medical director Dr Peter Moodie said exemestane would be fully funded under a deal with pharmaceutical company Pfizer.
Exemestane, an aromatase inhibitor drug, can help to block the growth of hormone-dependent tumours by lowering the amount of oestrogen hormone in the body.
